This month, BioCentriq hosted a webinar called The Role of Platform Processes in Cell Therapy. It explored the challenges associated with cell therapy manufacturing, including high cost and complexity, and offered an alternate pathway for …
Read more
Upcoming Webinar: The Role of Platform Processes in Cell Therapy Manufacturing and Development Date & Time: September 13, 2023 | 02:00 PM EDT | Register Now! Cell therapies can revolutionize treatment possibilities, offering potential cures …
Read more
Discover how you can reduce timelines and costs, de-risk clinical trials and get to patients faster with BioCentriq’s LEAPTM platform for advanced therapies. Discover BioCentriq’s Capabilities Our team is ready to meet with you and …
Read more
BioCentriq is happy to announce that we’ve been selected to present our capabilities at this year’s Meeting on the Mesa. The conference is from October 10-12 and is in Carlsbad, California. Organized by the Alliance …
Read more
Dedicated to bringing you top experts in the field, Biotech Banter promises a host of thought leaders and experienced professionals that can provide you with insight you might otherwise miss. The first episode features Dr. …
Read more
In the fast-paced, funding-constrained world of drug therapy development, finding the right balance between speed, quality, and cost is crucial. Investing time and money in thorough research and development (R&D) is imperative for successful clinical manufacturing; …
Read more
Newark, New Jersey – June 27, 2023 – BioCentriq and Cytiva announced today that they have received funding from NIIMBL to develop a viral and exotoxin clearance platform for adeno-associated virus (AAV) manufacturing. The goal of …
Read more
If you attended this year’s jam-packed ISCT annual event in Paris, there’s a good chance you came across one of our five team members during the four-day meeting. As a CDMO specializing in cell therapy …
Read more
NEWARK, NJ, June 6, 2023 – BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy announced today that it has expanded its partnership with Kytopen, a Cambridge based startup spun out …
Read more
Proprietary Platform Moves Promising Cell Therapy Candidates from Contract to Clinic in Six Months NEWARK, NJ, June 1, 2023 – BioCentriq®, a strategic CDMO (contract development and manufacturing organization) specializing in cell therapy launched their …
Read more
The LEAP™ advanced therapy platform offered by BioCentriq provides early-stage biotech companies with novel cell therapy candidates an avenue to leverage proven expertise and assets to reach patients in record time. Sponsors who leverage LEAP™ minimize up-front investment in process development, reduce risk, accelerate …
Read more
Accelerate Your Path to Clinic with BioCentriq’s LEAP™ Platform The LEAP™ platform offered by BioCentriq provides early-stage biotech companies with novel cell therapy candidates an avenue to leverage proven expertise and assets to reach …
Read more